基本信息·出版社：Academic Press ·页码：328 页 ·出版日期：2005年12月 ·ISBN：0123695333 ·条形码：9780123695338 ·装帧：平装 ·正文语种：英语 ...
| 商家名称 |
信用等级 |
购买信息 |
订购本书 |
|
|
 |
Drug Discovery: From Bedside to Wall Street |
 |
|
|
Drug Discovery: From Bedside to Wall Street |
|
基本信息·出版社：Academic Press
·页码：328 页
·出版日期：2005年12月
·ISBN：0123695333
·条形码：9780123695338
·装帧：平装
·正文语种：英语
·丛书名：Drug Discovery
·外文书名：药物发现: 从病床到华尔街
内容简介 在线阅读本书
Everyone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs 'work' medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable?
This book opens the windows and doors of the industry telling the story of drug development by using real stories from inside the process.
* Co-written by Graham Lees and Tamas Bartfai who has been involved in the development of drugs taken by more that 20 million people every day
* Opens the windows and doors of the most regulated industry in the world, the pharmaceutical industry
* Tells the story of drug development by using real examples based on current research and events
* Provides an objective, lucid account of the successes and failures, shortcomings and constraints of the pharmaceutical and biotech industries
* Gives insights into the development of new drugs to combat multiple conditions including cancer and pain
* Balanced, unbiased account of how better to translate basic science into drug discovery
编辑推荐 Review "Doody's 3 Star Review: It was refreshing reading about these matters from a different perspective. The critical nature of the book, I would imagine, was intentional to play the proverbial "devil's advocate". This book truly caused me to rethink some attitudes and opinions I have had about pharmaceutical company behavior in the marketplace. It's nice that once in a while such a refreshing publication comes along." - Albert Wertheimer, B.S., MBA, PhD, Temple University School of Pharmacy for DOODY'S "[This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants!" - Dennis W. Choi, M.D., Sr. VP Merck (2006) "Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie." - Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006) "...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things." - Richard Nass, Vanderbilt University (2006)
Review "Doody's 3 Star Review: It was refreshing reading about these matters from a different perspective. The critical nature of the book, I would imagine, was intentional to play the proverbial "devil's advocate". This book truly caused me to rethink some attitudes and opinions I have had about pharmaceutical company behavior in the marketplace. It's nice that once in a while such a refreshing publication comes along."
- Albert Wertheimer, B.S., MBA, PhD, Temple University School of Pharmacy for DOODY'S
"[This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants!"
- Dennis W. Choi, M.D., Sr. VP Merck (2006)
"Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie."
- Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006)
"...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things."
- Richard Nass, Vanderbilt University (2006)
